A Case of Prostate Cancer Harboring Androgen Receptor T878A Progesterone-Responsive Mutant Emerging After Abiraterone Acetate Treatment Responding to Darolutamide.

Varkaris, Andreas; Stevens, Julia; Ono, Yuho; Balk, Steven P; Bellmunt, Joaquim

Varkaris, Andreas; Stevens, Julia; Ono, Yuho; Balk, Steven P; Bellmunt, Joaquim.

Afiliación

Varkaris A; Division of Hematology-Oncology, Department of Medicine, and Cancer Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
Stevens J; Division of Hematology-Oncology, Department of Medicine, and Cancer Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
Ono Y; Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School. Boston, MA.
Balk SP; Division of Hematology-Oncology, Department of Medicine, and Cancer Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.
Bellmunt J; Division of Hematology-Oncology, Department of Medicine, and Cancer Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.

JCO Precis Oncol ; 6: e2100091, 2022 02.

Article en En | MEDLINE | ID: mdl-35201849

Asunto(s)

Neoplasias de la Próstata; Receptores Androgénicos; Acetato de Abiraterona/farmacología; Humanos; Masculino; Progesterona; Neoplasias de la Próstata/tratamiento farmacológico; Pirazoles; Receptores Androgénicos/genética

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Receptores Androgénicos Límite: Humans / Male Idioma: En Revista: JCO Precis Oncol Año: 2022 Tipo del documento: Article País de afiliación: Marruecos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google